Its last paragraph:

Despite all the remaining challenges, scientists say there is no denying the magnitude of the advance made last week. “It’s exciting, it’s seminal, it’s major — quite frankly I think it’s potentially Nobel-level,” said Dr. Kenneth R. Chien, director of the cardiovascular disease program at the Harvard Stem Cell Institute. “But there’s still a lot more work to do.”